BIOLUX P-III BENELUX Investigating the safety and efficacy of Passeo-18 Lux DCB for the treatment of isolated popliteal artery lesions Clinical trials: 24-Months Presentation at CIRSE 2023:
BIOLUX P-III BENELUX Investigating the safety and efficacy of Passeo-18 Lux DCB for the treatment of isolated popliteal artery lesions